H. Costeff, N. Gadoth, N. Apter, M. Prialnic, and H. Savir, A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia, Neurology, vol.39, pp.595-602, 1989.

H. Costeff, O. Elpeleg, N. Apter, P. Divry, and N. Gadoth, 3-Methylglutaconic aciduria in "optic atrophy plus, Ann Neurol, vol.33, pp.103-107, 1993.

Y. Anikster, R. Kleta, A. Shaag, W. A. Gahl, and O. Elpeleg, Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews, Am J Hum Genet, vol.69, pp.1218-1242, 2001.

R. Garcin, P. Raverdy, S. Delthil, H. X. Man, and H. Chimenes, On a heredo-familial disease combining cataract, optic atrophy, extrapyramidal symptoms and certain defects of Friedreich's diesease. (Its nosological position in relation to the Behr's syndrome, the Marinesco-Sjogren syndrome and Friedreich's disease with ocular symptoms, Rev Neurol, vol.104, pp.373-382, 1961.

M. Huizing, H. Dorward, L. Ly, E. Klootwijk, R. Kleta et al., OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria, Mol Genet Metab, vol.100, pp.149-54, 2010.

S. W. Ryu, H. J. Jeong, M. Choi, M. Karbowski, and C. Choi, Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation, Cell Mol Life Sci, vol.67, pp.2839-50, 2010.

D. Cruz, S. Xenarios, I. Langridge, J. Vilbois, F. Parone et al., Proteomic analysis of the mouse liver mitochondrial inner membrane, J Biol Chem, vol.278, pp.41566-71, 2003.

P. Reynier, P. Amati-bonneau, C. Verny, A. Olichon, G. Simard et al., OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract, J Med Genet, vol.41, p.110, 2004.

L. F. Burbulla, C. Schelling, H. Kato, D. Rapaport, D. Woitalla et al., Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis, Hum Mol Genet, vol.19, pp.4437-52, 2010.

B. Delprat, D. Schaer, S. Roy, J. Wang, J. L. Puel et al., FXYD6 is a novel regulator of Na,K-ATPase expressed in the inner ear, J Biol Chem, vol.282, pp.7450-7456, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00173536

G. Engl, S. Florian, L. Tranebjaerg, and D. Rapaport, Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology, Hum Mol Genet, vol.21, pp.287-99, 2012.

P. Luciano, S. Geoffroy, A. Brandt, J. F. Hernandez, and V. Geli, Functional cooperation of the mitochondrial processing peptidase subunits, J Mol Bio, vol.272, pp.213-238, 1997.

G. Krebiehl, S. Ruckerbauer, L. F. Burbulla, N. Kieper, B. Maurer et al., Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1, PLoS One, vol.5, p.9367, 2010.

W. J. Koopman, S. Verkaart, H. J. Visch, F. H. Van-der-westhuizen, M. P. Murphy et al., Inhibition of complex I of the electron transport chain causes O2-mediated mitochondrial outgrowth, Am J Physiol Cell Physiol, vol.288, pp.1440-1450, 2005.

M. Payne, Z. Yang, B. J. Katz, J. E. Warner, C. J. Weight et al., Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmo-plegia: a syndrome caused by a missense mutation in OPA1, Am J Ophthalmol, vol.138, pp.749-55, 2004.

C. Li, G. Kosmorsky, K. Zhang, B. J. Katz, J. Ge et al., Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation, Am J Med A, vol.138, pp.208-219, 2005.

G. Lenaers, C. P. Hamel, C. Delettre, P. Amati-bonneau, V. Procaccio et al., Dominant optic atrophy, Orphanet J Rare Dis, vol.7, p.46, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00767364

D. M. Walther and D. Rapaport, Biogenesis of mitochondrial outer membrane proteins, Biochim Biophys Acta, vol.1793, pp.42-51, 2009.

A. L. Misko, Y. Sasaki, E. Tuck, J. Milbrandt, and R. H. Baloh, Mitofusin 2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration, J Neurosci, vol.32, pp.4145-55, 2012.

J. Piquereau, F. Caffin, M. Novotova, A. Prola, A. Garnier et al., Downregulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload, Cardiovasc Res, vol.94, pp.408-425, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00871865

M. Ferré, D. Bonneau, D. Milea, A. Chevrollier, C. Verny et al., Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations, Hum Mutat, vol.30, pp.692-705, 2009.

M. Votruba, F. W. Fitzke, G. E. Holder, A. Carter, S. S. Bhattacharya et al., Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy, Arch Ophthalmol, vol.116, pp.351-359, 1998.

U. E. Pesch, B. Leo-kottler, S. Mayer, B. Jurklies, U. Kellner et al., OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance, Hum Mol Genet, vol.10, pp.1359-68, 2001.

D. L. Thiselton, C. Alexander, J. W. Taanman, S. Brooks, T. Rosenberg et al.,

M. Votruba, A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy, Invest Ophthalmol Vis Sci, vol.43, pp.1715-1739, 2002.

H. Eiberg, L. Hansen, B. Kjer, T. Hansen, O. Pedersen et al., Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene, J Med Genet, vol.43, pp.435-475, 2006.

R. Valéro, S. Bannwarth, S. Roman, V. Paquis-flucklinger, and B. Vialettes, Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 gene, Diabet Med, vol.25, pp.657-61, 2008.

B. Hogewind, R. Pennings, F. A. Hol, H. Kunst, E. H. Hoefsloot et al., Autosomal dominant optic neuropathy and sensorineural hearing loss associated with a novel mutation of WFS1, Mol Vis, vol.16, pp.26-35, 2010.

K. A. Powell, J. R. Davies, E. Taylor, M. A. Wride, and M. Votruba, Mitochondrial localization and ocular expression of mutant Opa3 in a mouse model of 3-methylglutaconicaciduria type III, Invest Ophthalmol Vis Sci, vol.52, pp.4369-80, 2011.

J. F. Buckman, H. Hernandez, G. J. Kress, T. V. Votyakova, S. Pal et al., MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants, J Neurosci Methods, vol.104, pp.165-76, 2001.

W. Pendergrass, N. Wolf, and M. Poot, Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues, Cytometry, vol.61, pp.162-171, 2004.

G. Twig, A. Elorza, A. J. Molina, H. Mohamed, J. D. Wikstrom et al., Fission and selective fusion govern mitochondrial segregation and elimination by autophagy, EMBO J, vol.27, pp.433-479, 2008.

H. Chen and D. C. Chan, Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases, Hum Mol Genet, vol.18, pp.169-76, 2009.

L. F. Burbulla, G. Krebiehl, and R. Krüger, Balance is the challenge-the impact of mitochondrial dynamics in Parkinson's disease, Eur J Clin Invest, vol.40, pp.1048-60, 2010.

C. Brooks, Q. Wei, L. Feng, G. Dong, Y. Tao et al., Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins, Proc Natl Acad Sci, vol.104, pp.11649-54, 2007.

A. K. Lutz, N. Exner, M. E. Fett, J. S. Schlehe, K. Kloos et al., Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation, J Biol Chem, vol.284, pp.22938-51, 2009.

E. I. Rugarli and T. Langer, Mitochondrial quality control: a matter of life and death for neurons, EMBO J, vol.31, pp.1336-1385, 2012.

A. Olichon, L. Baricault, N. Gas, E. Guillou, A. Valette et al., Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis, J Biol Chem, vol.278, pp.7743-7749, 2003.

A. Geissler, T. Krimmer, U. Bömer, B. Guiard, J. Rassow et al., Membrane potential-driven protein import into mitochondria. The sorting sequence of cytochrome b 2 modulates the ??-dependence of translocation of the matrix-targeting sequence, Mol Biol Cell, vol.11, pp.3977-91, 2000.

S. M. Claypool, J. M. Mccaffery, and C. M. Koehler, Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins, J Cell Biol, vol.174, pp.379-90, 2006.

N. Gebert, A. S. Joshi, S. Kutik, T. Becker, M. Mckenzie et al., Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome, Curr Biol, vol.19, pp.2133-2142, 2009.

J. A. Jarvis, M. T. Ryan, N. J. Hoogenraad, D. J. Craik, and P. B. Hoj, Solution structure of the acetylated and noncleavable mitochondrial targeting signal of rat chaperonin 10, J Biol Chem, vol.270, pp.1323-1354, 1995.

M. Waltner and H. Weiner, Conversion of a nonprocessed mitochondrial precursor protein into one that is processed by the mitochondrial processing peptidase, J Biol Chem, vol.270, pp.26311-26318, 1995.

P. K. Hammen, D. G. Gorenstein, and H. Weiner, Amphiphilicity determines binding properties of three mitochondrial presequences to lipid surfaces, Biochemistry, vol.35, pp.3772-81, 1996.